Trials / Conditions / Acquired Immune Deficiency Syndrome

Acquired Immune Deficiency Syndrome

13 registered clinical trials studyying Acquired Immune Deficiency Syndrome — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	WiseApp for Spanish Speakers Living With HIV NCT05398185	Columbia University	N/A
Completed	A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence NCT01741844	Janssen Korea, Ltd., Korea	—
Completed	Dose Optimisation of Stavudine for the Treatment of HIV Infection NCT02670772	Willem Daniel Francois Venter	Phase 3
Completed	A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista NCT01741831	Janssen Korea, Ltd., Korea	—
Withdrawn	A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells NCT01173510	Community Research Initiative of New England	Phase 4
Completed	Pilot Study of a Raltegravir Based NRTI Sparing Regimen NCT00814879	Yale University	N/A
Unknown	Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients NCT00872417	Peking Union Medical College	Phase 4
Unknown	Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Je NCT00758212	Hadassah Medical Organization	N/A
Terminated	Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease NCT00775606	Rush University Medical Center	Phase 4
Completed	Mentor Mothers: A Sustainable Family Intervention in South African Townships NCT00972699	University of California, Los Angeles	Phase 2
Terminated	Reactogenicity and Immunogenicity of Vaginal CNgp140 NCT00637962	St George's, University of London	Phase 1
Unknown	Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus NCT00499434	UPECLIN HC FM Botucatu Unesp	—
Completed	Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients NCT00055185	Progenics Pharmaceuticals, Inc.	Phase 2